Bomberman,
I like your use of probabilities. To me, that's the only way to make sense of this mess.
I get the feeling that the first column was retrosigmoid, but morphed into retrosigmoid followed by radiosurgery.
I would have the table as follows:
Retrosigmoid
+radiosurgery radiosurgery
facial nerve preservation 92.3% 97.3%
hearing preservation 11.6% 55.8%
That gives retrosigmoid + radiotherapy a 2.9 times higher failure rate for facial nerve and twice the failure rate for hearing preservation. You may want to look at trigeminal neuropathy.
The reasoning for the altered figures is as follows:
Retrosigmoid then radiosurgery facial function preservationhttp://thejns.org/doi/pdf/10.3171/2011.7.JNS101921, facial nerve preservation is 96.6% not 97%. Not much of a difference, but to me it suggests bias. Other figures go to a decimal point after the integer, but not this one.
Also, n = 151, since of the 383 patients, 151 commenced with microsurgical resection.
ttps://www.ncbi.nlm.nih.gov/pubmed/25065850 n = 151 since only 151 patients were followed postopersative. The preservation of facial function was 142/151 = 94.0%
I’ll add another interesting paper which is
http://www.karger.com/Article/Abstract/447520 from 2106, n = 22, which shows facial function preservation in 86.4% of cases.
Given them equal weight, retrosigmopid + radiosurgery has facial function preservation at 92.3%. So, personally, I would have this figure rather than 96.7%
Retrosigmoid then radiosurgery hearing preservationhttps://www.ncbi.nlm.nih.gov/pubmed/25065850, n = 129 has hearing preservation at 11.6%
https://www.ncbi.nlm.nih.gov/pubmed/23749017 is not applicable since it’s for retrosigmoid only.
Radiosurgery facial function preservationhttps://www.ncbi.nlm.nih.gov/pubmed/26508404 has facial function preservation at 94 to 100%. In the absence of other information , let’s call it 97%.
https://www.ncbi.nlm.nih.gov/pubmed/21353158 has facial and trigeminal nerve preservation >95%. Taking out the trigeminal nerve and considering the > sign, let’s also set this at 97%.
I’ll add two interesting paper which are
http://bmjopen.bmj.com/content/3/2/e001345.full.pdf+html which has facial neuropathy at 1% and
http://appliedradiationoncology.com/articles/interdisciplinary-management-of-acoustic-neuromas which has facial aspects at 96%
Radiosurgery hearing preservationhttps://www.ncbi.nlm.nih.gov/pubmed/25077322 n>4000 patients, for marginal does <13 Gy, has hearing preservation sat 60.5%. Marginal dose is something that under your control.
https://www.anausa.org/component/docman/doc_download/448-2014-patient-survey-report-final?Itemid=357 n>1000 appears to have hearing preservation at 30.5%
https://www.ncbi.nlm.nih.gov/pubmed/19303780 n=5825 has a hearing preservation at 59%
The same two interesting papers
http://bmjopen.bmj.com/content/3/2/e001345.full.pdf+html which has hearing preservation at 52% and
http://appliedradiationoncology.com/articles/interdisciplinary-management-of-acoustic-neuromas which has hearing preservation at 63% (Table 2) and 70% (Table 3)
Given them equal weight results in a average of 55.8%.
This flips things in favour of radiosurgery only.
Regards.